137 Cancer Drugs Are About to Get Up to 70% Cheaper in India
From November 9, the government caps pharmacy and distributor margins at 30%. Markups of 300–1,000% on common cancer drugs are no longer allowed.
- Retail inflation hits 5.5%, a near two-year high
- Food regulator tightens rules on infant nutrition products
- IDBI Bank privatization closes at ₹53,000 crore
India makes 20% of the world's generic medicines, yet Indians often paid more for the same drugs than patients in some African countries.